Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Chongqing Zhifei Biological Products Co., Ltd.
  6. News
  7. Summary
    300122   CNE100000V20

CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.

(300122)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2023-02-05
95.78 CNY   -1.86%
01/29Zhifei Biological Products Renews Supply Deal With Merck
MT
2022Chongqing Zhifei Biological's Shares Surge After Rollout of 2nd-Generation COVID-19 Vaccine
MT
2022Zhifei Biological Posts 36% Rise in Q3 Profit
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022

10/27/2022 | 04:12am EST

Chongqing Zhifei Biological Products Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 27,823.29 million compared to CNY 21,828.66 million a year ago. Revenue was CNY 27,823.29 million compared to CNY 21,828.66 million a year ago.

Net income was CNY 5,607.16 million compared to CNY 8,403.61 million a year ago. Basic earnings per share from continuing operations was CNY 3.5045 compared to CNY 5.2523 a year ago. Diluted earnings per share from continuing operations was CNY 3.5045 compared to CNY 5.2523 a year ago.


ę S&P Capital IQ 2022
All news about CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
01/29Zhifei Biological Products Renews Supply Deal With Merck
MT
2022Chongqing Zhifei Biological's Shares Surge After Rollout of 2nd-Generation COVID-19 Vac..
MT
2022Zhifei Biological Posts 36% Rise in Q3 Profit
MT
2022Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Mo..
CI
2022Zhifei Biological's H1 Profit Tanks 32% as Costs Outweigh Revenue
MT
2022Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Half Ye..
CI
2022Chongqing Zhifei Biological Products Co., Ltd. Announces Final Dividend on A Shares for..
CI
2022Some Omicron sub-variants escaping antibodies from Sinopharm shot -Chinese study
RE
2022Chongqing Zhifei Biological Products Co., Ltd. Approves Cash Dividend for the Year 2021
CI
2022UBS Adjusts Chongqing Zhifei Biological Products' Price Target to 163 Yuan From 175 Yua..
MT
More news
Analyst Recommendations on CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
More recommendations
Financials
Sales 2022 33 290 M 4 901 M 4 901 M
Net income 2022 7 629 M 1 123 M 1 123 M
Net cash 2022 7 927 M 1 167 M 1 167 M
P/E ratio 2022 20,2x
Yield 2022 1,06%
Capitalization 153 B 22 564 M 22 564 M
EV / Sales 2022 4,37x
EV / Sales 2023 3,43x
Nbr of Employees 4 800
Free-Float 14,7%
Chart CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
Duration : Period :
Chongqing Zhifei Biological Products Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Last Close Price 95,78 CNY
Average target price 125,12 CNY
Spread / Average Target 30,6%
EPS Revisions
Managers and Directors
Ren Sheng Jiang Chairman & General Manager
Zhen Jing Li Chief Financial Officer
Yu Qin Wu Chairman-Supervisory Board
Bao Kui Liu Independent Director
Gang Deng Independent Director
Sector and Competitors